Skip to main content
Log in

The Sociobiologic Integrative Model (SBIM): Enhancing the Integration of Sociobehavioral, Environmental, and Biomolecular Knowledge in Urban Health and Disparities Research

  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

Disentangling the myriad determinants of disease, within the context of urban health or health disparities, requires a transdisciplinary approach. Transdisciplinary approaches draw on concepts from multiple scientific disciplines to develop a novel, integrated perspective from which to conduct scientific investigation. Most historic and contemporary conceptual models of health were derived either from the sociobehavioral sciences or the biomolecular sciences. Those models deriving from the sociobehavioral sciences generally lack detail on involved biological mechanisms whereas those derived from the biomolecular sciences largely do not consider socioenvironmental determinants. As such, advances in transdisciplinary characterizations of health in complex systems like the urban environment or health disparities may be impeded. This paper suggests a sociobiologic organizing model that encourages a multilevel, integrative perspective in the study of urban health and health disparities.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

FIGURE 1
FIGURE 2

Similar content being viewed by others

References

  1. Birch S. The 39 steps: the mystery of health inequalities in the UK. Health Econ. 1999;8(4):301–308.

    Article  PubMed  CAS  Google Scholar 

  2. Macintyre S. The black report and beyond: what are the issues? Soc Sci Med. 1997;44(6):723–745.

    Article  PubMed  CAS  Google Scholar 

  3. Macintyre S, Ellaway A, Cummins S. Place effects on health: how can we conceptualise, operationalise and measure them? Soc Sci Med. 2002;55(1):125–139.

    Article  PubMed  Google Scholar 

  4. Acheson D. Independent Inquiry into Inequalities in Health. London: The Stationery Office; 1998.

  5. Adler NE, Ostrove JM. Socioeconomic status and health: what we know and what we don’t. Ann N Y Acad Sci. 1999;896:3–15.

    Article  PubMed  CAS  Google Scholar 

  6. Fuhrer R, Shipley MJ, Chastang JF et al. Socioeconomic position, health, and possible explanations: a tale of two cohorts. Am J Public Health. 2002;92(8):1290–1294.

    PubMed  CAS  Google Scholar 

  7. Williams DR. Race, socioeconomic status, and health. The added effects of racism and discrimination. Ann N Y Acad Sci. 1999;896:173–188.

    Article  PubMed  CAS  Google Scholar 

  8. Baum A, Garofalo JP, Yali AM. Socioeconomic status and chronic stress. Does stress account for SES effects on health? Ann N Y Acad Sci 1999;896:131–144.

    Article  PubMed  CAS  Google Scholar 

  9. Capitman J, Bhalotra SM, Calderon-Rosado V, Gibbons MC. Cancer Prevention and Treatment Demonstration for Racial and Ethnic Minorities; Evidence Report and Evidence-based Recommendations. USA: US Department of Health and Human Services; 2003:500-00-0031.

  10. LaLonde M. A New Perspective on the Health of Canadians. Canada: Government of Canada; 1981.

  11. Evans RG, Stoddart GL. Producing health, consuming health care. Soc Sci Med. 1990;31(12):1347–1363.

    Article  PubMed  CAS  Google Scholar 

  12. Burger R, Gimelfarb A. Genetic variation maintained in multilocus models of additive quantitative traits under stabilizing selection. Genetics 1999;152(2):807–820.

    PubMed  CAS  Google Scholar 

  13. Phillips TJ, Belknap JK. Complex-trait genetics: emergence of multivariate strategies. Nat Rev Neurosci. 2002;3(6):478–485.

    PubMed  CAS  Google Scholar 

  14. Sharma AM. The thrifty-genotype hypothesis and its implications for the study of complex genetic disorders in man. J Mol Med. 1998;76(8):568–571.

    Article  PubMed  CAS  Google Scholar 

  15. Meyer JM, Breitner JC. Multiple threshold model for the onset of Alzheimer’s disease in the NAS-NRC twin panel. Am J Med Genet. 1998;81(1):92–97.

    Article  PubMed  CAS  Google Scholar 

  16. Baron RM, Kenny DA. The moderator-mediator variable distinction in social psychological research: conceptual, strategic, and statistical considerations. J Pers Soc Psychol. 1986;51(6):1173–1182.

    Article  PubMed  CAS  Google Scholar 

  17. Minamoto T, Mai M, Ronai Z. Environmental factors as regulators and effectors of multistep carcinogenesis. Carcinogenesis. 1999;20(4):519–527.

    Article  PubMed  CAS  Google Scholar 

  18. Stucker I, Hirvonen A, de Waziers I et al. Genetic polymorphisms of glutathione S-transferases as modulators of lung cancer susceptibility. Carcinogenesis 2002;23(9):1475–1481.

    Article  PubMed  Google Scholar 

  19. Berkman LF, Kawachi I. Social Epidemiology. New York: Oxford University Press; 2000.

    Google Scholar 

  20. LaVeist TA. Race and Health. San Francisco: Jose-Bass; 2002.

    Google Scholar 

  21. Amick BC, Levine S, Tarlov AR, Walsh DC. Society and Health. New York: Oxford University Press; 1995.

    Google Scholar 

  22. Garfinkel A, Spano ML, Ditto WL, Weiss JN. Controlling cardiac chaos. Science 1992;257(5074):1230–1235.

    Article  PubMed  CAS  Google Scholar 

  23. Weiss JN, Garfinkel A, Spano ML, Ditto WL. Chaos and chaos control in biology. J Clin Invest. 1994;93(4):1355–1360.

    Article  PubMed  CAS  Google Scholar 

  24. Olsen LF, Schaffer WM. Chaos versus noisy periodicity: alternative hypotheses for childhood epidemics. Science 1990;249(4968):499–504.

    Article  PubMed  CAS  Google Scholar 

  25. Tidd CW, Olsen LF, Schaffer WM. The case for chaos in childhood epidemics. II. Predicting historical epidemics from mathematical models. Proc Biol Sci. 1993;254(1341):257–273.

    Article  PubMed  CAS  Google Scholar 

  26. Pargament KI, Maton KI, Hess RE. Religion and Prevention in Mental Health. Binghamton, NY: Hawthorne Press; 1992.

    Google Scholar 

  27. Evans RG, Barer ML, Marmor TR. Why are Some People Healthy and Others Not? The Determinants of Population Health. New York: Aldine De Gruyter, 1994.

    Google Scholar 

  28. Wadsworth ME. Health inequalities in the life course perspective. Soc Sci Med. 1997;44(6):859–869.

    Article  PubMed  CAS  Google Scholar 

  29. Christenson RH, Azzazy HM. Biochemical markers of the acute coronary syndromes. Clin Chem. 1998;44(8 Pt 2):1855–1864.

    PubMed  CAS  Google Scholar 

  30. Braunwald E, Jameson JL, Longo DL, Hauser SL, Kasper DL, Fauci AS. Harrisson’s Textbook of Medicine 15th Ed. New York: McGraw-Hill Publishers, 2001.

    Google Scholar 

  31. Cattell V. Poor people, poor places, and poor health: the mediating role of social networks and social capital. Soc Sci Med. 2001;52(10):1501–1516.

    Article  PubMed  CAS  Google Scholar 

  32. Wilson SH, Jones L, Coussens C, Hanna K, eds. Cancer and the Environment; Gene–Environment Interaction. Washington, DC: National Academy Press, 2002.

  33. Ulrich CM, Kampman E, Bigler J et al. Colorectal adenomas and the C677T MTHFR polymorphism: evidence for gene-environment interaction? Cancer Epidemiol Biomarkers Prev. 1999;8(8):659–668.

    PubMed  CAS  Google Scholar 

  34. Mucci LA, Wedren S, Tamimi RM, Trichopoulos D, Adami HO. The role of gene-environment interaction in the aetiology of human cancer: examples from cancers of the large bowel, lung and breast. J Intern Med. 2001;249(6):477–493.

    Article  PubMed  CAS  Google Scholar 

  35. Slattery ML, Curtin K, Ma K et al. Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev. 2002;11(6):541–548.

    PubMed  CAS  Google Scholar 

  36. Friedman EM, Lawrence DA. Environmental stress mediates changes in neuroimmunological interactions. Toxicol Sci. 2002;67(1):4–10.

    PubMed  CAS  Google Scholar 

  37. Kelada SN, Kardia SL, Walker AH, Wein AJ, Malkowicz SB, Rebbeck TR. The glutathione S-transferase-mu and -theta genotypes in the etiology of prostate cancer: genotype-environment interactions with smoking. Cancer Epidemiol Biomarkers Prev. 2000;9(12):1329–1334.

    PubMed  CAS  Google Scholar 

  38. Kramer MS, Goulet L, Lydon J et al. Socio-economic disparities in preterm birth: causal pathways and mechanisms. Paediatr Perinat Epidemiol. 2001;15(Suppl 2):104–123.

    Article  PubMed  Google Scholar 

  39. Goldman R, Shields P. Food mutagens. J Nutr. 2003;133:965s–973s.

    PubMed  CAS  Google Scholar 

  40. Alberg AJ, Samet JM. Epidemiology of lung cancer. Chest. 2003;123(1 Suppl):21S–49S.

    Article  PubMed  Google Scholar 

  41. Kharitonov SA, Barnes PJ. Exhaled markers of pulmonary disease. Am J Respir Crit Care Med. 2001;163(7):1693–1722.

    PubMed  CAS  Google Scholar 

  42. Montuschi P, Collins JV, Ciabattoni G et al. Exhaled 8-isoprostane as an in vivo biomarker of lung oxidative stress in patients with COPD and healthy smokers. Am J Respir Crit Care Med. 2000;162(3 Pt 1):1175–1177.

    PubMed  CAS  Google Scholar 

  43. De Servi B, La Porta CA, Bontempelli M, Comolli R. Decrease of TGF-beta1 plasma levels and increase of nitric oxide synthase activity in leukocytes as potential biomarkers of Alzheimer’s disease. Exp Gerontol. 2002;37(6):813–821.

    Article  PubMed  Google Scholar 

  44. Andreasen N, Blennow K. Beta-amyloid (Abeta) protein in cerebrospinal fluid as a biomarker for Alzheimer’s disease. Peptides 2002;23(7):1205–1214.

    Article  PubMed  CAS  Google Scholar 

  45. Meyer JM, Ginsburg GS. The path to personalized medicine. Curr Opin Chem Biol. 2002;6(4):434–438.

    Article  PubMed  CAS  Google Scholar 

  46. Pitot HC. The host-tumor relationship. In: Pitot HC, ed. Fundamentals of Oncology. New York: Marcel Dekker, Inc.; 2002:743–781.

    Google Scholar 

  47. Franceschi S, Bidoli E. The epidemiology of lung cancer. Ann Oncol. 1999;10(Suppl 5):S3–S6.

    Article  PubMed  Google Scholar 

  48. Morello-Frosch R, Pastor M, Porras C, Sadd J. Environmental justice and regional inequality in southern California: Implications for future research. Environ Health Perspect. 2002;110(Suppl 2):149–154.

    PubMed  Google Scholar 

  49. Kinney P, Chillrud S, Ramstrom S, Ross J, Stansfeld SA. Exposure to multiple air toxics in New York city. Environ Health Perspect. 2002;110(Suppl 4):539–546.

    PubMed  CAS  Google Scholar 

  50. Hecht SS. Tobacco smoke carcinogens and lung cancer. J Natl Cancer Inst. 1999;91(14):1194–1210.

    Article  PubMed  CAS  Google Scholar 

  51. Benowitz NL. Smoking and occupational health. In: Ladou J, ed. Occupational and Environmental Medicine. Stamford: Appleton and Lange; 1997:713–722.

    Google Scholar 

  52. Fielding JE, Husten CG, Eriksen MP. Tobacco: health effects and control. In: Wallace RB, ed. Public Health and Preventive Medicine. Stamford, CT: Appleton and Lange; 1998:817–846.

    Google Scholar 

  53. Kyle A, Woodruff T, Buffler P, Davis D. Use of an index to reflect the aggregate burden of long-term exposure to criteria air pollutants in the United States. Environ Health Perspect. 2002;110(Suppl 1):95–102.

    PubMed  CAS  Google Scholar 

  54. Sorenson M, Autrup H, Hertel O, Wallin H, Knudson E, Logan RA. Personal exposure to PM2.5 and biomarkers of DNA damage. Cancer Epidemiol Biomarkers Prev. 2003;12:191h–196h.

    Google Scholar 

  55. Belinsky SA, Snow SS, Nikula KJ, Finch GL, Tellez CS, Palmisano WA. Aberrant CpG island methylation of the p16(INK4a) and estrogen receptor genes in rat lung tumors induced by particulate carcinogens. Carcinogenesis 2002;23(2):335–339.

    Article  PubMed  CAS  Google Scholar 

  56. Zmirou D, Masclet P, Boudet C, Dor F, Dechenaux J. Personal exposure to atmospheric polycyclic aromatic hydrocarbons in a general adult population and lung cancer risk assessment. J Occup Environ Med. 2000;42(2):121–126.

    Article  PubMed  CAS  Google Scholar 

  57. Pope C, Burnett R, Thun M et al. Lung cancer, cardiopulmonary mortality, and long-term exposure to fine particulate air pollution. JAMA. 2002;287(1132):1141.

    Google Scholar 

  58. Zhao B, Seow A, Lee EJ et al. Dietary isothiocyanates, glutathione S-transferase-M1, -T1 polymorphisms and lung cancer risk among Chinese women in Singapore. Cancer Epidemiol Biomarkers Prev. 2001;10(10):1063–1067.

    PubMed  CAS  Google Scholar 

  59. Yang CS, Chhabra SK, Hong JY, Smith TJ. Mechanisms of inhibition of chemical toxicity and carcinogenesis by diallyl sulfide (DAS) and related compounds from garlic. J Nutr. 2001;131(3s):1041S–1045S.

    PubMed  CAS  Google Scholar 

  60. Weisburger JH, Chung FL. Mechanisms of chronic disease causation by nutritional factors and tobacco products and their prevention by tea polyphenols. Food Chem Toxicol. 2002;40(8):1145–1154.

    Article  PubMed  CAS  Google Scholar 

  61. Morland K, Wing S, Diez RA. The contextual effect of the local food environment on residents’ diets: the atherosclerosis risk in communities study. Am J Public Health. 2002;92(11):1761–1767.

    PubMed  Google Scholar 

  62. LaVeist TA, Wallace JM, Jr. Health risk and inequitable distribution of liquor stores in African American neighborhood. Soc Sci Med. 2000;51(4):613–617.

    Article  Google Scholar 

  63. Alexandrov K, Cascorbi I, Rojas M, Bouvier G, Kriek E, Bartsch H. CYP1A1 and GSTM1 genotypes affect benzo[a]pyrene DNA adducts in smokers’ lung: comparison with aromatic/hydrophobic adduct formation. Carcinogenesis. 2002;23(12):1969–1977.

    Article  PubMed  CAS  Google Scholar 

  64. Haugen A, Ryberg D, Mollerup S, Zienolddiny S, Skaug V, Svendsrud DH. Gene–environment interactions in human lung cancer. Toxicol Lett. 2000;112–113:233–237.

    Article  PubMed  Google Scholar 

  65. Miller DP, Liu G, De Vivo I et al. Combinations of the variant genotypes of GSTP1, GSTM1, and p53 are associated with an increased lung cancer risk. Cancer Res. 2002;62(10):2819–2823.

    PubMed  CAS  Google Scholar 

  66. Lewis SJ, Cherry NM, Niven RM, Barber PV, Povey AC. GSTM1, GSTT1 and GSTP1 polymorphisms and lung cancer risk. Cancer Lett. 2002;180(2):165–171.

    Article  PubMed  CAS  Google Scholar 

  67. Kamataki T, Nunoya K, Sakai Y, Kushida H, Fujita K. Genetic polymorphism of CYP2A6 in relation to cancer. Mutat Res. 1999;428(1–2):125–130.

    PubMed  CAS  Google Scholar 

  68. Sunaga N, Kohno T, Yanagitani N et al. Contribution of the NQO1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility. Cancer Epidemiol Biomarkers Prev. 2002;11(8):730–738.

    PubMed  CAS  Google Scholar 

  69. Song N, Tan W, Xing D, Lin D. CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China. Carcinogenesis. 2001;22(1):11–16.

    Article  PubMed  CAS  Google Scholar 

  70. Itoga S, Nomura F, Makino Y, Tomonaga T, Shimada H, Ochiai T et al. Tandem repeat polymorphism of the CYP2E1 gene: an association study with esophageal cancer and lung cancer. Alcohol Clin Exp Res. 2002;26(8 Suppl):15S–19S.

    PubMed  CAS  Google Scholar 

  71. Shields PG. Molecular epidemiology of lung cancer. Ann Oncol. 1999;10(Suppl 5):S7–11.

    Article  PubMed  Google Scholar 

  72. Samet JM. What can we expect from epidemiologic studies of chemical mixtures? Toxicology. 1995;105:307–314.

    Article  PubMed  CAS  Google Scholar 

  73. Feron V, Groten J. Toxicologic evaluation of chemical mixtures. Food Chem Toxicol. 2002;40:825–839.

    Article  PubMed  CAS  Google Scholar 

  74. Mauderly J. Toxicological approaches to complex mixtures. Environ Health Perspect. 1993;101(Suppl 4):155–165.

    Article  PubMed  CAS  Google Scholar 

  75. Pitot HC. Fundamentals of Oncology, 4th edn. New York, NY: Marcel Dekker, Inc.; 2002.

    Google Scholar 

  76. Medelsohn J, Howley PM, Isreal MA, Liotta LA. The Molecular Basis of Cancer, 2nd edn. Philadelphia, PA: WB Saunders; 2001.

    Google Scholar 

  77. Terry L. Smoking and Health: A report of the Surgeon General. USA: DHHS; 1964.

  78. Zochbauer-Muller S, Gazdar AF, Minna JD. Molecular pathogenesis of lung cancer. Annu Rev Physiol. 2002;64:681–708.

    Article  PubMed  CAS  Google Scholar 

  79. Schuller HM. Mechanisms of smoking-related lung and pancreatic adenocarcinoma development. Nat Rev Cancer. 2002;2(6):455–463.

    Article  PubMed  CAS  Google Scholar 

  80. Hecht SS. Human urinary carcinogen metabolites: biomarkers for investigating tobacco and cancer. Carcinogenesis. 2002;23(6):907–922.

    Article  PubMed  CAS  Google Scholar 

  81. Pastorino U, Berrino F, Gervasio A, Pesenti V, Riboli E, Crosignani P. Proportion of lung cancers due to occupational exposure. Int J Cancer. 1984;33(2):231–237.

    Article  PubMed  CAS  Google Scholar 

  82. Archer VE, Wagoner JK, Lundin FE. Lung cancer among uranium miners in the United States. Health Phys. 1973;25(4):351–371.

    Article  PubMed  CAS  Google Scholar 

  83. Cancer Facts and Figures 2003. Washington, DC: American Cancer Society; 2003.

  84. National Center for Health Statistics. Early Release of Selected Estimates Based on Data from the 2001 National Health Interview Survey. Available at http://www.cdc.gov/nchs/about/major/nhis/released200207.htm#early. USA: CDC, National Center for Health Statistics; 2003.

  85. Garfinkel L. Trends in cigarette smoking in the United States. Prev Med. 1997;26(4):447–450.

    Article  PubMed  CAS  Google Scholar 

  86. Zang EA, Wynder EL. Smoking trends in the United States between 1969 and 1995 based on patients hospitalized with non-smoking-related diseases. Prev Med. 1998;27(6):854–861.

    Article  PubMed  CAS  Google Scholar 

  87. Murray LR. Sick and tired of being sick and tired: scientific evidence, methods, and research implications for racial and ethnic disparities in occupational health. Am J Public Health. 2003;93(2):221–226.

    Article  PubMed  Google Scholar 

Download references

Acknowledgment

This research was supported by funding from the National Institute of Aging (5U01AG018033), National Cancer Institute (5U01CA086308), and National Institute of Environmental Health Sciences (ES03819). Dr. Alberg is a recipient of a KO7 award from the National Cancer Institute (CA73790).

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. Chris Gibbons.

Additional information

Gibbons and Fox are with the Johns Hopkins Urban Health Institute, Baltimore, MD, USA; Brock, Baylin, and Levine are with the Johns Hopkins School of Medicine, Baltimore, MD, USA; Gibbons, Alberg, LaVeist, Levine, and Fox are with the Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA; Brock, Alberg, and Baylin are with the Johns Hopkins Oncology Center, Baltimore, MD, USA; Gibbons and LaVeist are with the Johns Hopkins Center for Health Disparities Studies, Baltimore, MD, USA; Glass is with the Johns Hopkins Bloomberg School of Public Health Center on Aging and Health, Baltimore, MD, USA.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gibbons, M.C., Brock, M., Alberg, A.J. et al. The Sociobiologic Integrative Model (SBIM): Enhancing the Integration of Sociobehavioral, Environmental, and Biomolecular Knowledge in Urban Health and Disparities Research. J Urban Health 84, 198–211 (2007). https://doi.org/10.1007/s11524-006-9141-7

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11524-006-9141-7

Keywords

Navigation